296 related articles for article (PubMed ID: 35193609)
1. Safety and efficacy of a probiotic-containing infant formula supplemented with 2'-fucosyllactose: a double-blind randomized controlled trial.
Alliet P; Vandenplas Y; Roggero P; Jespers SNJ; Peeters S; Stalens JP; Kortman GAM; Amico M; Berger B; Sprenger N; Cercamondi CI; Corsello G
Nutr J; 2022 Feb; 21(1):11. PubMed ID: 35193609
[TBL] [Abstract][Full Text] [Related]
2. Term infant formula supplemented with milk-derived oligosaccharides shifts the gut microbiota closer to that of human milk-fed infants and improves intestinal immune defense: a randomized controlled trial.
Estorninos E; Lawenko RB; Palestroque E; Sprenger N; Benyacoub J; Kortman GAM; Boekhorst J; Bettler J; Cercamondi CI; Berger B
Am J Clin Nutr; 2022 Jan; 115(1):142-153. PubMed ID: 34617558
[TBL] [Abstract][Full Text] [Related]
3. Linking Human Milk Oligosaccharides, Infant Fecal Community Types, and Later Risk To Require Antibiotics.
Berger B; Porta N; Foata F; Grathwohl D; Delley M; Moine D; Charpagne A; Siegwald L; Descombes P; Alliet P; Puccio G; Steenhout P; Mercenier A; Sprenger N
mBio; 2020 Mar; 11(2):. PubMed ID: 32184252
[TBL] [Abstract][Full Text] [Related]
4. Infant Formula With a Specific Blend of Five Human Milk Oligosaccharides Drives the Gut Microbiota Development and Improves Gut Maturation Markers: A Randomized Controlled Trial.
Bosheva M; Tokodi I; Krasnow A; Pedersen HK; Lukjancenko O; Eklund AC; Grathwohl D; Sprenger N; Berger B; Cercamondi CI;
Front Nutr; 2022; 9():920362. PubMed ID: 35873420
[TBL] [Abstract][Full Text] [Related]
5. Effects of Infant Formula With Human Milk Oligosaccharides on Growth and Morbidity: A Randomized Multicenter Trial.
Puccio G; Alliet P; Cajozzo C; Janssens E; Corsello G; Sprenger N; Wernimont S; Egli D; Gosoniu L; Steenhout P
J Pediatr Gastroenterol Nutr; 2017 Apr; 64(4):624-631. PubMed ID: 28107288
[TBL] [Abstract][Full Text] [Related]
6. Real-world study in infants fed with an infant formula with two human milk oligosaccharides.
Román E; Moreno Villares JM; Domínguez Ortega F; Carmona Martínez A; Picó Sirvent L; Santana Sandoval L; Casas Rivero J; Alshweki A; Cercamondi C; Dahbane S; Vidal Guevara ML
Nutr Hosp; 2020 Aug; 37(4):698-706. PubMed ID: 32698596
[TBL] [Abstract][Full Text] [Related]
7. Infant formula containing bovine milk-derived oligosaccharides supports age-appropriate growth and improves stooling pattern.
Estorninos E; Lawenko RB; Palestroque E; Lebumfacil J; Marko M; Cercamondi CI
Pediatr Res; 2022 May; 91(6):1485-1492. PubMed ID: 33958719
[TBL] [Abstract][Full Text] [Related]
8. Infants Fed a Lower Calorie Formula With 2'FL Show Growth and 2'FL Uptake Like Breast-Fed Infants.
Marriage BJ; Buck RH; Goehring KC; Oliver JS; Williams JA
J Pediatr Gastroenterol Nutr; 2015 Dec; 61(6):649-58. PubMed ID: 26154029
[TBL] [Abstract][Full Text] [Related]
9. Growth and safety evaluation of infant formulae containing oligosaccharides derived from bovine milk: a randomized, double-blind, noninferiority trial.
Meli F; Puccio G; Cajozzo C; Ricottone GL; Pecquet S; Sprenger N; Steenhout P
BMC Pediatr; 2014 Dec; 14():306. PubMed ID: 25527244
[TBL] [Abstract][Full Text] [Related]
10. Early Benefits of a Starter Formula Enriched in Prebiotics and Probiotics on the Gut Microbiota of Healthy Infants Born to HIV+ Mothers: A Randomized Double-Blind Controlled Trial.
Cooper P; Bolton KD; Velaphi S; de Groot N; Emady-Azar S; Pecquet S; Steenhout P
Clin Med Insights Pediatr; 2016; 10():119-130. PubMed ID: 28096702
[TBL] [Abstract][Full Text] [Related]
11. Similar to Those Who Are Breastfed, Infants Fed a Formula Containing 2'-Fucosyllactose Have Lower Inflammatory Cytokines in a Randomized Controlled Trial.
Goehring KC; Marriage BJ; Oliver JS; Wilder JA; Barrett EG; Buck RH
J Nutr; 2016 Dec; 146(12):2559-2566. PubMed ID: 27798337
[TBL] [Abstract][Full Text] [Related]
12. Randomized controlled trial on the impact of early-life intervention with bifidobacteria on the healthy infant fecal microbiota and metabolome.
Bazanella M; Maier TV; Clavel T; Lagkouvardos I; Lucio M; Maldonado-Gòmez MX; Autran C; Walter J; Bode L; Schmitt-Kopplin P; Haller D
Am J Clin Nutr; 2017 Nov; 106(5):1274-1286. PubMed ID: 28877893
[No Abstract] [Full Text] [Related]
13. A Partly Fermented Infant Formula with Postbiotics Including 3'-GL, Specific Oligosaccharides, 2'-FL, and Milk Fat Supports Adequate Growth, Is Safe and Well-Tolerated in Healthy Term Infants: A Double-Blind, Randomised, Controlled, Multi-Country Trial.
Vandenplas Y; de Halleux V; Arciszewska M; Lach P; Pokhylko V; Klymenko V; Schoen S; Abrahamse-Berkeveld M; Mulder KA; Porcel Rubio R; On Behalf Of The Voyage Study Group
Nutrients; 2020 Nov; 12(11):. PubMed ID: 33233658
[TBL] [Abstract][Full Text] [Related]
14. Fecal microbiota composition of breast-fed infants is correlated with human milk oligosaccharides consumed.
Wang M; Li M; Wu S; Lebrilla CB; Chapkin RS; Ivanov I; Donovan SM
J Pediatr Gastroenterol Nutr; 2015 Jun; 60(6):825-33. PubMed ID: 25651488
[TBL] [Abstract][Full Text] [Related]
15. Real-world evidence study on tolerance and growth in infants fed an infant formula with two human milk oligosaccharides vs mixed fed and exclusively breastfed infants.
Jochum F; Meyer-Krott M; Hübler T; Lorenz M; Bedikian R; Zakarian J; Litzka A; Judex G; Hertzberg H; Klee D; Maurer L; Schacht M; Al-Radhi A; Maier J; Kröckel A; Faustmann C; Lavalle L; Dahbane S
Mol Cell Pediatr; 2023 Aug; 10(1):7. PubMed ID: 37597076
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal change of selected human milk oligosaccharides and association to infants' growth, an observatory, single center, longitudinal cohort study.
Sprenger N; Lee LY; De Castro CA; Steenhout P; Thakkar SK
PLoS One; 2017; 12(2):e0171814. PubMed ID: 28182762
[TBL] [Abstract][Full Text] [Related]
17. Effects of prebiotic-containing infant formula on gastrointestinal tolerance and fecal microbiota in a randomized controlled trial.
Holscher HD; Faust KL; Czerkies LA; Litov R; Ziegler EE; Lessin H; Hatch T; Sun S; Tappenden KA
JPEN J Parenter Enteral Nutr; 2012 Jan; 36(1 Suppl):95S-105S. PubMed ID: 22237884
[TBL] [Abstract][Full Text] [Related]
18. Effects of addition of 2-fucosyllactose to infant formula on growth and specific pathways of utilization by
Wallingford JC; Neve Myers P; Barber CM
Front Nutr; 2022; 9():961526. PubMed ID: 36211486
[TBL] [Abstract][Full Text] [Related]
19. Early Effect of Supplemented Infant Formulae on Intestinal Biomarkers and Microbiota: A Randomized Clinical Trial.
Castanet M; Costalos C; Haiden N; Hascoet JM; Berger B; Sprenger N; Grathwohl D; Brüssow H; De Groot N; Steenhout P; Pecquet S; Benyacoub J; Picaud JC
Nutrients; 2020 May; 12(5):. PubMed ID: 32443684
[TBL] [Abstract][Full Text] [Related]
20. Sialylated galacto-oligosaccharides and 2'-fucosyllactose reduce necrotising enterocolitis in neonatal rats.
Autran CA; Schoterman MH; Jantscher-Krenn E; Kamerling JP; Bode L
Br J Nutr; 2016 Jul; 116(2):294-9. PubMed ID: 27212112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
